Whatever You do you

Blueheel I feel much better about the direction of the development of the molecule. I did sell most of my shares at 6 and have gotten back in with Dr Jay leading the direction. I focused on Ohm’s research on other boards and inflammation is always key in his explanations. A few building block tests explaining the method of action, peer reviewed papers and the share price will nudge up. That’s my belief. This is relatively a small holding for me.

Whatever. Go bother someone else

I have my own opinions and theories about the share price. Not really interested in this board for investment advice. Thanks anyway.

Agree, feel the same about Misiu. This board used to be a discussion about the science….this board has been circling the drain for quite some time and of no value. I actually just drop by to check on Misiu

Merry Christmas Misiu!

Happy Mother’s Day Misiu!

Happy New Year Misiu! Here’s to good health to you and your family.

Misiu, thank you for posting this. I appreciate you.

Roll call - still here - still long. Go CYDY

Hey Misiu! Still here. Still long. GLTU

Thanks DolphinTom. Me too

Hope all is well with you Misiu!

I thought the bond was only for the audit, not access to their data. Access to their data was granted.

Sadly, my mother-in-law decided to not continue her battle. It was too debilitating for her. Keep plugging Cytodyn team.

These trades are done in your firms block account and allocated at the end of the day. Whatever the quantity.

Well if someone decided to sell today for tax loss, it would have to be a cash trade done by the desk - so nothing out of the ordinary. Means nothing.

Yes and I’m more comfortable with current staffing than in the past. We have a much better skill set. Dr Jay’s continued belief in LL keeps me believing.

It only takes one approval. Our statisticians have access to our data via Amarex or directly from the trial sites. My opinion is there are enough wealthy individuals who have lost loved ones to The diseases OHM has on his list who will carry this forward. God willing.

I’d like to revisit this thought in January when the tax sales are not part of the equation. My opinion is we have more employees with the scientific and mathematical degrees necessary to move forward toward approval.

Our trial in Brazil is for critical, on a ventilator, too late for the pill. The pill is useful when you’ve been exposed, and works in the first five days. It can’t be taken with those with kidney or liver disease, and may interact poorly with certain blood thinners, high blood pressure meds - basically the same ailments that causes people to be hospitalized from COVID. LL has not interacted negatively with other drugs. There are also published papers of success for many on a vent. I’d enroll.

18

Kush regularly attended the conferences we were invited to and spoke to the medical professionals. Dr Berger was the CMO. He didn’t publicly question or discredit Amarex. Per a prior conference e call, The FDA recommended Amarex to CYDY after we bought PRO140. Our trials were floundering prior to that. I don’t think anything became apparent until after 2019 - around the time Amarex was acquired. Anyway, Merry Christmas to Nader & team and all longs pulling for this company.

In my opinion, a company who has already paid one firm over 60 million $ would expect their data to be sufficiently organized to submit a contracted BLA in timely manor. 3 months, 6 months, 12, 24?! Good grief. The trial is done. We’re talking data management 101.

He was probably focused on his real job, saving lives.

I’m very , very sorry to learn you lost your brother. I’m sorry for your loss.

Can’t they bring in a new CRO to contact the trial location(s)?

I guess you are forgetting that it was THIS management that got Leronlimab to His wife and saved her life.

Prayers for your brother Hook. And praying his wife is able to get Leronlimab for him.

Just wondering how many fines Pfizer has paid in the past.

Non-live meetings during a pandemic caused a firm to stop following?

Wasn’t Dr Patterson part of that deal? We didn’t hear much about it again after the pandemic.

Still quoted and coverage just initiated by Citi

The FDA doesn’t respect NP or Amarex. People aligned with the 13D say the FDA doesn’t respect NP. I don’t know that - their public letter said they’re quite willing to assist with trial design and from what has been published in trial protocols, Dr Rechnor has had discussions with them with Longhaulers.

You are ignoring the additions of Dr Rechnor and Dr Ray and their capabilities. I’d recommend googling speeches given by Dr Ray in his past positions at other organizations. He’s brilliant.

I have no idea what strategy the attorneys are employing. When it’s over, we’ll know.

What I do know is Leronlimab binds to CCR5. We appear to have competent, dedicated people overseeing the current trials. I voted yes for the 200 myn additional shares. Onward.

We’ll find out in the court case. You don’t know what the CRO was telling Nader. You don’t know. Your agenda is clear.

Agree.

No, outstanding share increases are done at annual meetings of shareholders. Annual.

Respect!! Thanks Rockleo. Finally a loud, knowledgeable voice of reason today!